Is neoadjuvant chemoradiotherapy a feasible strategy for stage IIIA-N2 non-small cell lung cancer? Mature results of the randomized IFCT-0101 phase II trial. [electronic resource]
Producer: 20101103Description: 86-93 p. digitalISSN:- 1872-8332
- Antineoplastic Combined Chemotherapy Protocols
- Carboplatin -- administration & dosage
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Cisplatin -- administration & dosage
- Deoxycytidine -- administration & dosage
- Feasibility Studies
- Female
- Follow-Up Studies
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Neoadjuvant Therapy
- Neoplasm Recurrence, Local
- Neoplasm Staging
- Paclitaxel -- administration & dosage
- Survival Analysis
- Vinblastine -- administration & dosage
- Vinorelbine
- Gemcitabine
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.